Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from FDA

Genmab/AbbVie Partnered Blood Cancer Combination Drug Cuts Risk Of Disease Progression By 79%

Genmab A/S (NASDAQ:GMAB) released results Thursday of the Phase 3 EPCORE FL-1 trial evaluating subcutaneous epcoritamab in combination with rituximab and lenalidomide (R2) versus R2 alone for adult patients with relapsed or refractory (R/R) follicular lymphoma (FL).

Benzinga

Boston Scientific Reports 16 Deaths Linked To Defibrillator Lead Issue

The Food and Drug Administration (FDA) said on Wednesday it is monitoring a potential safety issue involving Boston Scientific Corporation’s (NYSE:BSX) ENDOTAK RELIANCE defibrillation leads, following a letter from the company alerting healthcare providers of possible reduced shock efficacy.

Benzinga

19 Fatal TikTok Challenges That Went Too Far And Ended In Real Tragedies

These TikTok challenges uncovered the dark side of social media...

Bored Panda

From analysis to the latest developments in health,
read the most diverse news in one place.

FTC Sounds Alarm On Edwards' Attempt To Corner Heart Device Market

The Federal Trade Commission (FTC) on Wednesday moved to block medical device supplier Edwards Lifesciences Corp.'s (NYSE:EW) proposed acquisition of JenaValve Technology, Inc.

Benzinga

Gilead Sciences Lifts Annual Outlook As Yeztugo Launch Nears

Gilead Sciences (NASDAQ:GILD) announced its second-quarter 2025 earnings and revised annual outlook after the market closed on Thursday.

Benzinga

8 Ingredients That Were Once Banned but Are Now Quietly Back

The world of food regulation is a constantly evolving field, where new scientific research can lead to a reversal of long-standing rules. Several ingredients that were once banned or heavily restricted by the U.S. Food and Drug Administration (FDA) due to health concerns have been quietly allowed back into our…

Grocery Coupon Guide

Tempus AI Raises Outlook, CEO Cites Faster-Than-Expected Growth And Improved Margins

Tempus AI Inc. (NASDAQ:TEM) reported second-quarter financial results Friday.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Experts reveal the hidden health side effects of lash serums

Not all lash serums are created equal, and the key difference lies in the ingredients

The Independent UK

Health risk warning issued as popular sweetener is recalled

IN FULL

The Independent UK

Popular sweetener recalled over labeling mix-up as FDA issues warning

The recall was recently upgraded by the FDA, the latest in a string affecting consumers

The Independent UK

Exact Sciences Dip A Chance To Buy As Freenome Deal Fortifies Future: Analyst

Exact Sciences Corp. (NYSE:EXAS) on Thursday reported a second-quarter 2025 EPS loss of 1 cent, up from a 9-cent loss a year ago, beating the analyst consensus loss estimate of 19 cents.

Benzinga

9 “All Natural” Snacks That Still Contain Artificial Colors

The “all-natural” label on a snack food is a powerful marketing tool that can make you feel good about your purchase. However, because the FDA does not regulate the term, food companies can use it on products that contain highly processed and artificial ingredients. One of the most striking examples…

Grocery Coupon Guide

Longer lashes, lasting damage? What to know about lash serums

Longer, darker lashes are having a moment. For those avoiding the risk or expense of lash extensions, serums can seem like a safer, more affordable option. But not all lash serums are created equal – and some come with hidden side-effects.

The Conversation

EXCLUSIVE: Intelligent Bio Expects Double Digit Topline Growth In Q4

Intelligent Bio Solutions Inc. (NASDAQ:INBS) reported preliminary fiscal fourth quarter revenue results and selected operational highlights on Thursday.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Grocery Coupon Guide

8 Times Store Brands Outsold the Name Brand—But Weren’t Safer

Store brands have exploded in popularity over the last decade. They often promise the same quality as name brands at a lower cost—and sometimes, they even outsell their more expensive counterparts. But when it comes to safety, not all store brands are created equal. In fact, there have been several…

The Independent UK

Warning issued as man dies after taking ‘addictive’ supplement

IN FULL

The Independent UK

Family issues warning as son dies after taking highly addictive over-the-counter supplement: ‘The government doesn’t step in’

The U.S. Food and Drug Administration has suggested classifying an addictive kratom offshoot as an illicit substance

The Independent UK

FDA flags problems with two Boston Scientific heart devices tied to injuries and deaths

U.S. health officials have issued warnings on two separate Boston Scientific heart devices recently linked to injuries and deaths

Get all your
news in one place.

100's of premium titles.
One news app.

We Got This Covered

This ‘natural’ milk trend is sending kids to the hospital and Florida officials say it’s getting worse

It all started with a RFK Jr. tweet.

Everybody Loves Your Money

How Buying Discount Vitamins Online Can Land You on Health Fraud Watchlists

Scoring a great deal on vitamins online feels like a win—until it lands your name on a health fraud watchlist. Behind that colorful label and suspiciously low price could be a product flagged by federal agencies. Health authorities, including the FDA and FTC, monitor supplement sales closely, especially those peddled…

International Business Times UK

Shocking Reason Why The NFL Banned Smelling Salts and Why Players Use Them in the First Place

The NFL has banned smelling salts from all games starting in 2025, citing FDA warnings about safety concerns and the substances' potential to mask concussion symptoms, leaving players like George Kittle threatening retirement over the controversial decision.

Benzinga

Ozempic Maker Novo Nordisk Terminates Multiple Pipeline Programs, Faces Investor Lawsuit Over GLP-1 Market Misrepresentation

Novo Nordisk A/S (NYSE:NVO) on Wednesday reported second-quarter 2025 sales of roughly $11.68 billion (76.86 billion Danish kroner), missing the consensus of $11.79 billion.

The Guardian - UK

As influencers spread ‘toxic’ claims, what is the truth about sunscreen?

Too much exposure to the sun has traditionally been seen as a danger. Now claims that sunscreen is toxic flood the internet. What does the science say?

The Independent UK

‘We will work collaboratively’: Big Pharma admits it is discussing Trump’s plan to lower drug prices

Pfizer CEO says drugmakers ‘are all ready to roll up their sleeves and execute’ as president demands more direct-to-consumer options

The Independent UK

Laura Loomer’s MAGA critics accuse her of being funded by Big Pharma

‘I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The Independent

1 … 33 34 35 36

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

Federal Trade Commission

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.